There's a lot of excitement around uniQure's AMT-130 #genetherapy program at #EHDN2024! Today Prof. Ed Wild presented the latest AMT-130 data to this important meeting of the European #Huntingtonsdisease community.
uniQure’s Post
More Relevant Posts
-
#ESCMIDGlobal attendees, deep dive into the tackling of #AMR holistically in the Cepheid Integrated Lunch Panel & Symposium, from a macro, political, clinical, and patient perspective, analysing the key challenges faced, practical solutions, and central role of diagnostics as our best defense against resistance. Register: https://lnkd.in/eE-KYQRk
-
-
Deep dive into the tackling of #AMR holistically in the Cepheid Integrated Lunch Panel & Symposium at #ESCMIDGlobal, from a macro, political, clinical, and patient perspective, analysing the key challenges faced, practical solutions, and central role of diagnostics as our best defense against resistance. Register: https://lnkd.in/e6P2688s
-
-
Check out the upcoming webinar on 'hot takes' in precision medicine moderated by Katie Maloney!
Live from London! We're hosting a webinar with TTP plc next month! Join us for a dynamic panel discussion featuring key opinion leaders taking the hot seat to share their contrarian thoughts on the most pressing issues in the precision medicine space. This webinar promises engaging insights, thought-provoking discussions, and the opportunity to witness minds being changed in real-time. In the Hot Seat: Challenging Conventions in Precision Medicine Thursday, March 7th, 2024 3:00 pm - 4:00 pm GMT / 10:00 am - 11:00 am EST Registration is limited. Save your spot today: https://lnkd.in/g-q7bZkx #PrecisionMedicine #AGBT24 #Webinar
-
Precision Medicine will help patients get more appropriate drugs? Duh! NGS is the future of genomics? Boring! Reimbursement will take time to catch up with innovation? Obviously! Enough with the popular opinions, we want contrarian perspectives! Join our webinar on March 7th to hear some of the industries leading KOLs share their hot takes in precision medicine and have a chance to vote on if your mind has been changed. Find the registration link below!
Live from London! We're hosting a webinar with TTP plc next month! Join us for a dynamic panel discussion featuring key opinion leaders taking the hot seat to share their contrarian thoughts on the most pressing issues in the precision medicine space. This webinar promises engaging insights, thought-provoking discussions, and the opportunity to witness minds being changed in real-time. In the Hot Seat: Challenging Conventions in Precision Medicine Thursday, March 7th, 2024 3:00 pm - 4:00 pm GMT / 10:00 am - 11:00 am EST Registration is limited. Save your spot today: https://lnkd.in/g-q7bZkx #PrecisionMedicine #AGBT24 #Webinar
In the Hot Seat: Challenging Conventions in Precision Medicine
info.ttp.com
-
Save the date
EuroPCR 2024 is coming soon, and we are looking forward to meeting you from May 14th to 17th in Paris! Join us at booth M14 to discover the future of our drug-coated and eluting technologies with the dedicated “Meet The Expert” discussions on clinical data release: ➡️ XLIMIT RCT: Update on 4-Year Results with Dr. Luca Testa (Milan, Italy) 🗓️ Tuesday, May 14th 🕒 10:30 (Session 1) 🕒 15:00 (Session 2) ➡️ HYPER I Trial Results and Introduction to HYPER II Study, with Dr. Alfonso Ielasi (Milan, Italy) 🗓️ Wednesday, May 15th (Session 1) 🕒 15:00 🗓️ Thursday, May 16th (Session 2) 🕒 12:00 More info at: www.cardionovum.com #Cardionovum #RESTORE #DCB #Safepax #drugcoatedballoon #XLIMUS #DES #EuroPCR #PCR2024 #medicaldevices #coronaryintervention #Lifedeservesthebest
-
Associate Professor of Pediatrics, Cell Biology, and Physiology. Director, PCD and Rare lung disease program.
Our latest work is now appearing in JCI insight, where we describe the transcriptional profile of primary airway cells from subjects with PCD, and identify a unique expression profile in their cells compared to unaffected controls. We also identify a dedicated cilia expression of GSTA2. The video render shows the expression of GSTA2, a glutathione-s-transferase, within the airway cilia. Its levels is significantly increased in PCD patients. https://lnkd.in/exmyWpP8
-
Updates on #MitraClip from #TCT2024
First COAPT. Now RESHAPE-HF2. Two positive randomized clinical trials for #MitraClip #TEER. At #TCT2024 Prof. Stefan Anker and Dr. Ralph Stephan von Bardeleben presented more compelling analyses from RESHAPE-HF2. This further aligns with results from the COAPT Trial and demonstrates the effectiveness of MitraClip TEER for moderate-to-severe or severe SMR in patients with HF. Learn more about MitraClip: https://abbo.tt/MitraClip Important Safety Info: https://lnkd.in/dNT4vGyc #StructuralHeart
-
We look forward to #ISPOR 2024 conference in Atlanta, GA. Our team has submitted an abstract showcasing the use of #GoalAttainmentScaling as a personalized endpoint in clinical trials over the last decade. #patientcentricity #clinicaloutcomes #goalattainmentscaling #PFDD
-
-
Cardiologist and researcher at the Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf
So much new data to process! Excellent for science and for our patients with device-detected AF. Check out the published paper on CHADSVASc 5-9 and anticoagulation https://lnkd.in/eSRhm2aA #EHRA #AFNET #atrialfibrillation
The Atrial Fibrillation NETwork (AFNET) is an interdisciplinary research network dedicated to improving the management of atrial fibrillation.
😀 Fascinating science and full house at #EHRA2024! Patients with device-detected #afib do not benefit from #anticoagulation! Enjoy reading the just published subanalysis of the #NOAHtrial https://lnkd.in/eNCJVSS4 and the corresponding press release: https://lnkd.in/edXpSr7M Julius Nikorowitsch Paulus Kirchhof Dr. med. Nina Becher (geb. Fluschnik) Dr. Vincent Beuger Wolfgang Dichtl Daniel Scherr Renate Schnabel Ulrich Schotten Emmanuel Simantirakis Tobias Toennis Antonia Zapf #AFNET
-
-
I recommend this EBAC accredited online seminar on Mon Oct 14th 2024 dealing with life-threatening hemorrhage associated with Direct Oral AntiCoagulants (DOACs). With the increasing use of these drugs in clinical practice, we in Emergency medicine need to familiar with managing their relatively infrequent but dreaded complication.
PeerVoice - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED
cme.peervoice.com
Independent Business Owner @ EFH | Chemical Engineering
1moTen years.